DCGI Approval for Pulse Pharma's Nano Vitamin D3
Hyderabad-based Pulse Pharmaceuticals announced that it has received approval from the Drugs Controller General of India (DCGI) for its nano-carrier entrapped Vitamin D3 oral medication. Speaking here on Thursday, the company's founder and MD, KV Rambabu, stated that the regulatory body granted this approval following rigorous scientific testing. He noted that this is the first time globally that such approval has been granted for a Vitamin D3 medication utilizing nanotechnology.
You Might Also Like
-
Hyderabad-based Pulse Pharmaceuticals announced that it has received approval from the Drugs Cont...
-
Gold prices recorded an increase on Saturday as well, driven by international geopolitical factor...
Leave A Comment
Comments